Backed by Science

Luminopia™ One is an investigational device developed closely with leading physicians and neuroscientists and builds upon years of published research. Although Luminopia One has not yet been approved by the FDA, pilot studies conducted on the therapeutic have demonstrated its potential to be an engaging and effective at-home treatment for amblyopia.

Supporting scientific literature

Luminopia One Therapeutic Pilot Research Abstract

Aaron M. Miller, MD; Lisa Bohra, MD; Christie Morse, MD; Louis Blumenfeld, MD; Noha Ekdawi, MD; Ann Stout, MD; Malcolm Mazow, MD; Eric Gaier, MD, PhD; Scott Xiao; David Hunter, MD

Luminopia Virtual Reality Amblyopia Treatment Pilot Study

Scott Xiao; Malcolm L. Mazow, MD; Ann U. Stout, MD

Binocular Therapy for Childhood Amblyopia Improves Vision Without Breaking Interocular Suppression

Bossi M, Tailor VK, Anderson EJ, Bex PJ, Greenwood JA, Dahlmann-Noor A, Dakin SC. Investigative Ophthalmology & Visual Science
2017; Volume 58: Pages 3031-3043

Binocular iPad Game vs Patching for Treatment of Amblyopia in Children

Kelly KR, Jost RM, Dao L. JAMA Ophthalmology
2016; Volume 134: Pages 1402-1408

Dichoptic movie viewing treats childhood amblyopia

Li SL, Reynaud A, Hess RF, Wang Y, Birch EE, et al Journal of the AAPOS
2015; Volume 19: Pages 401-405

A binocular iPad treatment for amblyopic children

Li SL, Jost RM, Morale SE, Stager DR, Dao L, Stager D, Birch EE. Eye
2014; Volume 28: Pages 1246-1253